Why the study?
Assessment of LVEF and GLS has shown promise for predicting adverse cardiovascular events, but whether artificial intelligence-calculated LVEF and GLS are associated with MACE and all-cause mortality in chest pain patients required evaluation.
Does AI-calculated LVEF and GLS predict MACE and all-cause mortality in patients presenting with chest pain?
Does AI-calculated LVEF and GLS predict MACE and all-cause mortality in patients presenting with chest pain?
AI-calculated LVEF and GLS from resting echocardiograms independently predict long-term MACE and all-cause mortality in patients presenting with chest pain.
Supports the feasibility of automated echocardiographic risk stratification in acute chest pain; leaves open.
BACKGROUND: Assessment of left ventricular ejection fraction (LVEF) and myocardial deformation with global longitudinal strain (GLS) has shown promise in predicting adverse cardiovascular events. The aim of this study was to evaluate whether artificial intelligence (AI) calculated LVEF and GLS is associated with major adverse cardiac events (MACE) and all-cause mortality in patients presenting with chest pain. METHODS: We studied 296 patients presenting with chest pain, who underwent transthoracic echocardiography (TTE). Clinical data, downstream clinical investigations and patient outcomes were collected. Resting TTE images underwent AI contouring for automated calculation of LVEF and GLS with Ultromics EchoGo Core 2.0. Regression analysis was performed to identify clinical and AI calculated parameters associated with MACE and all-cause mortality. RESULTS: During a median follow-up period of 7.8 years (IQR 6.4, 8.8), MACE occurred in 34 (11.5%) patients and all-cause mortality in 60 (20%) patients. AI calculated LVEF (Odds Ratio [OR] .96; 95% CI .93-.99 and .96; 95% CI .93-.99) and GLS (1.11; 95% CI 1.01-1.21 and 1.08; 95% CI 1.00-1.16) were independently associated with MACE and all-cause mortality, respectively. According to Cox proportional hazards, a LVEF < 50% was associated with a 3.7 times MACE and 2.8 times all-cause mortality hazard rate compared to those with a LVEF ≥ 50%. Those with a GLS ≥ 15% was associated with a 2.5 times MACE and 2.3 times all-cause mortality hazard rate compared to those with a GLS ≤ 15. CONCLUSION: AI calculated resting LVEF and GLS is independently associated with MACE and all-cause mortality in high CVD risk patients. These results may have significant clinical implications through improved risk stratification of patients with chest pain, accelerated workflow of labour-intensive technical measures, and reduced healthcare costs.
No takes yet. Share an insight, caveat, or question.
O’Driscoll et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: